REVITIVE for the Treatment of Patients With Venous Insufficiency

NCT02114307 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2019-10-10

Study results available
· View outcomes & findings →

Summary

To investigate the efficacy of an electrical stimulation (using the REVITIVE IX device) in treating patients with venous insufficiency.

Conditions

  • Venous Insufficiency
  • Oedema
  • Varicose Veins

Interventions

DEVICE

REVITIVE IX

neuromuscular electrical stimulation device

Sponsors & Collaborators

  • Actegy Ltd.

    collaborator INDUSTRY
  • Imperial College London

    lead OTHER

Principal Investigators

  • Alun Davies, MA DM FRCS FHEA · Imperial College London and Imperial College London NHS Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-01
Primary Completion
2014-10-01
Completion
2014-10-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02114307 on ClinicalTrials.gov